Debates between Chris Elmore and Martin Whitfield during the 2017-2019 Parliament

Paediatric Cancers of the Central Nervous System

Debate between Chris Elmore and Martin Whitfield
Monday 22nd October 2018

(6 years, 1 month ago)

Commons Chamber
Read Full debate Read Hansard Text Read Debate Ministerial Extracts
Martin Whitfield Portrait Martin Whitfield (East Lothian) (Lab)
- Hansard - - - Excerpts

My hon. Friend is being generous with his time, debating an important subject that has been raised several times in this House. I rise to pay tribute to two constituents—Alex Logan and Luke Stewart—who lost their lives recently. I have spoken to the Minister and others about treatment abroad, and I urge the Minister and the NHS to look more widely for possible cures and to be—I phrase this carefully—more open-minded about where the answers may lie.

Chris Elmore Portrait Chris Elmore
- Hansard - -

I agree with my hon. Friend and endorse his tribute to his two constituents. I will speak later about some of my asks regarding international research, to which I hope the Minister will respond positively.

It is of course vital that we continue to undertake the best research possible into brain tumours in adults, but I must impress upon the Minister that it is essential that we give equal priority to childhood cancers. It is extremely positive to see groundbreaking work being undertaken in Wales, including through the Wales Cancer Research Centre, which is funded by the Welsh Government and led by Cardiff University. In recent years, it has been very positive to see the new drug/radiation combination trials coming to Wales, which could lead to new world-leading treatments being made available in the Welsh NHS. Clinicians and politicians of all political colours agree that this is an uphill struggle, but I know that it is a fight that colleagues in the Welsh Government will face head-on.

I pay tribute to the charities doing such vital work to advance research. I am pleased that the charity Brain Tumour Research is working closely with Cardiff University to fund research into some of the most aggressive forms of brain tumours. I know that Brain Tumour Research and CLIC Sargent have raised concerns about the hidden costs of treatments for the families of patients being treated for such cancers. CLIC Sargent finds that parents of children suffering from cancer spend as much as £600 a month on top of their normal travel expenses. We must work together, across health boundaries, to decrease that cost and provide financial support where possible.